1. Home
  2. HUMA vs EIC Comparison

HUMA vs EIC Comparison

Compare HUMA & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • EIC
  • Stock Information
  • Founded
  • HUMA 2004
  • EIC N/A
  • Country
  • HUMA United States
  • EIC United States
  • Employees
  • HUMA N/A
  • EIC N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • EIC Finance/Investors Services
  • Sector
  • HUMA Health Care
  • EIC Finance
  • Exchange
  • HUMA Nasdaq
  • EIC Nasdaq
  • Market Cap
  • HUMA 356.8M
  • EIC 343.8M
  • IPO Year
  • HUMA N/A
  • EIC 2019
  • Fundamental
  • Price
  • HUMA $2.48
  • EIC $12.17
  • Analyst Decision
  • HUMA Strong Buy
  • EIC Strong Buy
  • Analyst Count
  • HUMA 7
  • EIC 1
  • Target Price
  • HUMA $13.00
  • EIC $17.50
  • AVG Volume (30 Days)
  • HUMA 4.3M
  • EIC 399.7K
  • Earning Date
  • HUMA 08-11-2025
  • EIC 08-12-2025
  • Dividend Yield
  • HUMA N/A
  • EIC 19.70%
  • EPS Growth
  • HUMA N/A
  • EIC N/A
  • EPS
  • HUMA N/A
  • EIC 0.55
  • Revenue
  • HUMA $517,000.00
  • EIC $51,224,692.00
  • Revenue This Year
  • HUMA N/A
  • EIC $37.84
  • Revenue Next Year
  • HUMA $936.09
  • EIC $23.33
  • P/E Ratio
  • HUMA N/A
  • EIC $22.08
  • Revenue Growth
  • HUMA N/A
  • EIC 68.61
  • 52 Week Low
  • HUMA $1.15
  • EIC $12.10
  • 52 Week High
  • HUMA $8.24
  • EIC $16.71
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 53.95
  • EIC 26.76
  • Support Level
  • HUMA $2.14
  • EIC $12.90
  • Resistance Level
  • HUMA $2.39
  • EIC $13.15
  • Average True Range (ATR)
  • HUMA 0.21
  • EIC 0.28
  • MACD
  • HUMA -0.01
  • EIC -0.08
  • Stochastic Oscillator
  • HUMA 48.57
  • EIC 4.62

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About EIC Eagle Point Income Company Inc.

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

Share on Social Networks: